<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous experiments have demonstrated that positive selection markers recombined into the Epstein-Barr virus (EBV) genome enable the isolation of transforming or nontransforming mutant EBV recombinants in EBV-negative B-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines (A </plain></SENT>
<SENT sid="1" pm="."><plain>Marchini, J </plain></SENT>
<SENT sid="2" pm="."><plain>I </plain></SENT>
<SENT sid="3" pm="."><plain>Cohen, and E </plain></SENT>
<SENT sid="4" pm="."><plain>Kieff, J </plain></SENT>
<SENT sid="5" pm="."><plain>Virol </plain></SENT>
<SENT sid="6" pm="."><plain>66:3214-3219, 1992; F </plain></SENT>
<SENT sid="7" pm="."><plain>Wang, A </plain></SENT>
<SENT sid="8" pm="."><plain>Marchini, and E </plain></SENT>
<SENT sid="9" pm="."><plain>Kieff, J </plain></SENT>
<SENT sid="10" pm="."><plain>Virol </plain></SENT>
<SENT sid="11" pm="."><plain>65:1701-1709, 1991) </plain></SENT>
<SENT sid="12" pm="."><plain>However, virus has been recovered from a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell clone (BL41) infected with an EBV recombinant in only one instance (Wang et al., J </plain></SENT>
<SENT sid="13" pm="."><plain>Virol </plain></SENT>
<SENT sid="14" pm="."><plain>65:1701-1709, 1991) </plain></SENT>
<SENT sid="15" pm="."><plain>We now compare the utility of four EBV-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines, BJAB, BL30, BL41, and Loukes, for isolating EBV recombinants and supporting their subsequent replication </plain></SENT>
<SENT sid="16" pm="."><plain>Transforming or nontransforming EBV recombinants carrying a simian virus 40 promoter-<z:chebi fb="0" ids="24753">hygromycin</z:chebi> phosphotransferase (HYG) cassette were cloned by selecting newly infected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells for HYG expression </plain></SENT>
<SENT sid="17" pm="."><plain>Most of the infected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> clones contained EBV episomes, and EBV gene expression was largely restricted to EBNA-1 </plain></SENT>
<SENT sid="18" pm="."><plain>Although the BJAB cell line was a particularly good host for isolating EBV recombinants (Marchini et al., J </plain></SENT>
<SENT sid="19" pm="."><plain>Virol </plain></SENT>
<SENT sid="20" pm="."><plain>66:3214-3219, 1992), it was largely nonpermissive for virus replication, even in response to heterologous expression of the BZLF1 immediate-early transactivator </plain></SENT>
<SENT sid="21" pm="."><plain>In contrast, approximately 50% of infected BL41, BL30, or Loukes cell clones responded to lytic cycle induction </plain></SENT>
<SENT sid="22" pm="."><plain>Frequently, a substantial fraction of infected cells expressed the late lytic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> <z:mp ids='MP_0001799'>viral</z:mp> protein, gp350/220, and released infectious virus </plain></SENT>
<SENT sid="23" pm="."><plain>Since <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells do not depend on EBV for growth, transforming and nontransforming EBV recombinants were isolated and passaged </plain></SENT>
</text></document>